Boston Scientific (BSX): Rep. Lisa C. McClain (MI09) disclosed a sale $1K–$15K
Rep. Lisa C. McClain (MI09) disclosed a sale of Boston Scientific in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 22 days
- Disclosure lag
- Traded
- Oct 30, 2025
- Disclosed
- Nov 21, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 29, 2024CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
- Aug 4, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
- Sep 2, 2025Insider · 1 personInsiders: 2 sales (~$5.3M)
- Sep 23, 2025CongressDisclosed sale of BSX — reported range $1,001 - $15,000
- Sep 26, 2025FDAFDA device clearance: Radial Jaw 4 Pulmonary Biopsy Forceps
- Oct 9, 2025FDAFDA device clearance: Orca Air/Water and Suction Valves
- Oct 17, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
- Oct 22, 2025Company filing · Form 8-K · ResultsReported its results
- Oct 22, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 22, 2025, John E. Sununu informed Boston Scientific Corporation (the “Company”) that he will not stand for re-election at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”).”
- Oct 27, 2025InsiderDirector sold ~$1.01M of BSX shares in the open market
- Oct 28, 2025FDAFDA device clearance: TheraSphere 360 Y-90 Management Platform
- Oct 28, 2025InsiderDirector sold ~$297K of BSX shares in the open market
- Oct 28, 2025CongressDisclosed partial sale of BSX — reported range $15,001 - $50,000
- Oct 30, 2025 · this disclosureCongressDisclosed sale of BSX — reported range $1,001 - $15,000
What came next
- Oct 30, 2025FDAFDA device clearance: Moses 200 D/F/L Laser Fiber (M0068130100); Moses 365 D/F/L Laser Fiber (M0068130110); Moses 550 D/F/L Laser Fiber (M0068130120)
- Oct 30, 2025FDAFDA device clearance: OBSIDIO Conformable Embolic (M0013972101010)
- Oct 30, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
- Oct 31, 2025CongressDisclosed sale of BSX — reported range $1,001 - $15,000
- Nov 3, 2025Insider · 1 personInsiders: 3 sales (~$5.0M)
- Nov 6, 2025InsiderDirector sold ~$1.27M of BSX shares in the open market
- Nov 18, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 18, 2025, upon the recommendation of the Executive Compensation and Human Resources Committee (the “Compensation Committee”), the Board of Directors (the “Board”) of Boston Scientific Corporation (the “Company”) approved the Company’s 2026 Annual Bonus Plan effective for the performance year of January 1, 2026 through December 31, 2026 (the “2026 Annual Bonus Plan”).”
- Nov 18, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
- Dec 1, 2025InsiderOfficer sold ~$1.76M of BSX shares in the open market
- Dec 3, 2025FDARecall: Boston Scientific Coyote OVER-THE-WIRE PTA Balloon Dilation Catheter, 4F, 1) 2.5mm x120mm, 150 cm, UPM/Model No. REF H74939186251210; 2) 3.5mm x120mm, 150 cm,…
- Dec 16, 2025Federal contract · $519K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $519K obligated to date
- Dec 17, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
- Dec 19, 2025FDARecall: HOT AXIOS Stent and Electrocautery-Enhanced Delivery System 6mm x 8mm; Material Number (UPN): M00553520;
- Dec 19, 2025FDARecall: AXIOS Stent and Electrocautery-Enhanced Delivery System - 20mm x 10mm; Material Number (UPN): M00553660;
- Dec 19, 2025FDARecall: *HOT AXIOS Stent and Electrocautery-Enhanced Delivery System 20mm x 10mm; Material Number (UPN): M00553560;
- Dec 19, 2025FDARecall: AXIOS Stent and Electrocautery-Enhanced Delivery System - 6mm x 8mm; Material Number (UPN): M00553680;
- Dec 19, 2025FDARecall: *HOT AXIOS Stent and Electrocautery-Enhanced Delivery System 8mm x 8mm; Material Number (UPN): M00553530;
- Dec 19, 2025FDARecall: AXIOS Stent and Electrocautery-Enhanced Delivery System - 8mm x 8mm; Material Number (UPN): M00553690;
- Dec 24, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
- Dec 29, 2025CongressDisclosed purchase of BSX — reported range $15,001 - $50,000
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Boston Scientific
For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.
Other recent filings by Rep. Lisa C. McClain (MI09)
- House Clerk periodic transaction report at CACI (CACI)Oct 12, 2026
- House Clerk periodic transaction report at Caterpillar (CAT)Oct 12, 2026
- House Clerk periodic transaction report at Immunitybio (IBRX)Oct 12, 2026
- House Clerk periodic transaction report at Immunitybio (IBRX)Oct 12, 2026
- House Clerk periodic transaction report at Microsoft (MSFT)Oct 12, 2026
The full history of Rep. Lisa C. McClain (MI09) is on the profile page.
How this filing works
Explore the data
Common questions
Which member of Congress traded Boston Scientific (BSX) stock, and how much?
Rep. Lisa C. McClain (MI09) disclosed a sale of Boston Scientific in the $1K–$15K range. Reported range, not an exact amount, Spouse account.
When did it happen, and when was it made public?
Traded: Oct 30, 2025. Disclosed: Nov 21, 2025. That is 22 days between the two dates.
Why is the amount a range and not an exact figure?
Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.
Where does this information come from?
From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Boston Scientific recently?
For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the BSX page.
Does this mean BSX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Boston Scientific
- SEC Form 13F-HRNov 16, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
Everything OQRO holds on this company is on its BSX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
